{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T04:47:36Z","timestamp":1781758056601,"version":"3.54.5"},"reference-count":72,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100021171","name":"Basic and Applied Basic Research Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["2018B030311020"],"award-info":[{"award-number":["2018B030311020"]}],"id":[{"id":"10.13039\/501100021171","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021171","name":"Basic and Applied Basic Research Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["2021A1515220126"],"award-info":[{"award-number":["2021A1515220126"]}],"id":[{"id":"10.13039\/501100021171","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82073864"],"award-info":[{"award-number":["82073864"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82073895"],"award-info":[{"award-number":["82073895"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Biological Macromolecules"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1016\/j.ijbiomac.2022.11.152","type":"journal-article","created":{"date-parts":[[2022,11,17]],"date-time":"2022-11-17T02:49:43Z","timestamp":1668653383000},"page":"873-885","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"special_numbering":"C","title":["Cell membrane-camouflaged DOX-loaded \u03b2-glucan nanoparticles for highly efficient cancer immunochemotherapy"],"prefix":"10.1016","volume":"225","author":[{"given":"Mengting","family":"Lin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuqing","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiyue","family":"Long","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yueling","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhuo","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fengyun","family":"Zhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manmei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chaoxi","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"16","key":"10.1016\/j.ijbiomac.2022.11.152_bb0005","doi-asserted-by":"crossref","first-page":"R921","DOI":"10.1016\/j.cub.2020.06.081","article-title":"The tumor microenvironment","volume":"30","author":"Anderson","year":"2020","journal-title":"Curr. Biol."},{"key":"10.1016\/j.ijbiomac.2022.11.152_bb0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2021.121137","article-title":"M1 macrophage exosomes engineered to foster M1 polarization and target the IL-4 receptor inhibit tumor growth by reprogramming tumor-associated macrophages into M1-like macrophages","volume":"278","author":"Gunassekaran","year":"2021","journal-title":"Biomaterials"},{"issue":"1","key":"10.1016\/j.ijbiomac.2022.11.152_bb0015","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.immuni.2014.06.008","article-title":"Macrophage activation and polarization: nomenclature and experimental guidelines","volume":"41","author":"Murray","year":"2014","journal-title":"Immunity"},{"issue":"3","key":"10.1016\/j.ijbiomac.2022.11.152_bb0020","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.3390\/cancers6031670","article-title":"Tumor-associated macrophages as major players in the tumor microenvironment","volume":"6","author":"Chanmee","year":"2014","journal-title":"Cancers (Basel)"},{"issue":"2","key":"10.1016\/j.ijbiomac.2022.11.152_bb0025","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.molcel.2019.10.023","article-title":"Cancer-derived succinate promotes macrophage polarization and cancer metastasis via succinate receptor","volume":"77","author":"Wu","year":"2020","journal-title":"Mol. Cell"},{"issue":"1","key":"10.1016\/j.ijbiomac.2022.11.152_bb0030","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1038\/s41467-018-03225-9","article-title":"Chloroquine modulates antitumor immune response by resetting tumor-associated macrophages toward M1 phenotype","volume":"9","author":"Chen","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ijbiomac.2022.11.152_bb0035","series-title":"Multifunctional Nanoregulator Reshapes Immune Microenvironment and Enhances Immune Memory for Tumor Immunotherapy","first-page":"1900037","volume":"6 (16)","author":"Yu","year":"2019"},{"issue":"12","key":"10.1016\/j.ijbiomac.2022.11.152_bb0040","article-title":"A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent SMANCS","volume":"46","author":"Maeda","year":"1986","journal-title":"Cancer Res."},{"issue":"12","key":"10.1016\/j.ijbiomac.2022.11.152_bb0045","doi-asserted-by":"crossref","first-page":"3830","DOI":"10.1039\/C6CS00592F","article-title":"Nanoparticle design strategies for enhanced anticancer therapy by exploiting the tumour microenvironment","volume":"46","author":"Dai","year":"2017","journal-title":"Chem. Soc. Rev."},{"issue":"6","key":"10.1016\/j.ijbiomac.2022.11.152_bb0050","doi-asserted-by":"crossref","first-page":"904","DOI":"10.3892\/mco.2014.356","article-title":"Passive targeting of nanoparticles to cancer: a comprehensive review of the literature","volume":"2","author":"Bazak","year":"2014","journal-title":"Mol. Clin. Oncol."},{"issue":"2","key":"10.1016\/j.ijbiomac.2022.11.152_bb0055","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/s41573-020-0090-8","article-title":"Engineering precision nanoparticles for drug delivery","volume":"20","author":"Mitchell","year":"2021","journal-title":"Nat. Rev. Drug Discov."},{"issue":"3","key":"10.1016\/j.ijbiomac.2022.11.152_bb0060","doi-asserted-by":"crossref","DOI":"10.1002\/btm2.10143","article-title":"Nanoparticles in the clinic: an update","volume":"4","author":"Anselmo","year":"2019","journal-title":"Bioeng. Transl. Med."},{"issue":"8","key":"10.1016\/j.ijbiomac.2022.11.152_bb0065","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1016\/j.nano.2014.04.011","article-title":"Just so stories: the random acts of anti-cancer nanomedicine performance","volume":"10","author":"Moghimi","year":"2014","journal-title":"Nanomedicine"},{"key":"10.1016\/j.ijbiomac.2022.11.152_bb0070","doi-asserted-by":"crossref","first-page":"627","DOI":"10.3389\/fbioe.2020.00627","article-title":"Cell membrane-based biomimetic nanoparticles and the immune system: immunomodulatory interactions to therapeutic applications","volume":"8","author":"Sushnitha","year":"2020","journal-title":"Front. Bioeng. Biotechnol."},{"issue":"4","key":"10.1016\/j.ijbiomac.2022.11.152_bb0075","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.nantod.2015.06.006","article-title":"Nanoparticle uptake: the phagocyte problem","volume":"10","author":"Gustafson","year":"2015","journal-title":"Nano Today"},{"issue":"9","key":"10.1016\/j.ijbiomac.2022.11.152_bb0080","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1038\/nbt.3330","article-title":"Principles of nanoparticle design for overcoming biological barriers to drug delivery","volume":"33","author":"Blanco","year":"2015","journal-title":"Nat. Biotechnol."},{"issue":"25","key":"10.1016\/j.ijbiomac.2022.11.152_bb0085","doi-asserted-by":"crossref","first-page":"6972","DOI":"10.1016\/j.biomaterials.2014.04.099","article-title":"PEG-PCL based micelle hydrogels as oral docetaxel delivery systems for breast cancer therapy","volume":"35","author":"Wang","year":"2014","journal-title":"Biomaterials"},{"issue":"3","key":"10.1016\/j.ijbiomac.2022.11.152_bb0090","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1038\/nrd1033","article-title":"Effect of pegylation on pharmaceuticals","volume":"2","author":"Harris","year":"2003","journal-title":"Nat. Rev. Drug Discov."},{"issue":"1\u20133","key":"10.1016\/j.ijbiomac.2022.11.152_bb0095","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S0167-4889(02)00204-5","article-title":"Chemical camouflage of nanospheres with a poorly reactive surface: towards development of stealth and target-specific nanocarriers","volume":"1590","author":"Moghimi","year":"2002","journal-title":"Biochim. Biophys. Acta"},{"issue":"1","key":"10.1016\/j.ijbiomac.2022.11.152_bb0100","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1002\/biot.200900218","article-title":"PEGylation of therapeutic proteins","volume":"5","author":"Jevsevar","year":"2010","journal-title":"Biotechnol. J."},{"issue":"1","key":"10.1016\/j.ijbiomac.2022.11.152_bb0105","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.jconrel.2009.02.023","article-title":"Oxaliplatin encapsulated in PEG-coated cationic liposomes induces significant tumor growth suppression via a dual-targeting approach in a murine solid tumor model","volume":"137","author":"Abu Lila","year":"2009","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijbiomac.2022.11.152_bb0110","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.jconrel.2014.12.008","article-title":"Polyethylene glycol (PEG)-dendron phospholipids as innovative constructs for the preparation of super stealth liposomes for anticancer therapy","volume":"199","author":"Pasut","year":"2015","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijbiomac.2022.11.152_bb0115","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.biomaterials.2018.08.022","article-title":"The effect of surface poly(ethylene glycol) length on in vivo drug delivery behaviors of polymeric nanoparticles","volume":"182","author":"Wang","year":"2018","journal-title":"Biomaterials"},{"issue":"2","key":"10.1016\/j.ijbiomac.2022.11.152_bb0120","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.jconrel.2012.03.020","article-title":"Doxil(R)\u2013the first FDA-approved nano-drug: lessons learned","volume":"160","author":"Barenholz","year":"2012","journal-title":"J. Control. Release"},{"issue":"1","key":"10.1016\/j.ijbiomac.2022.11.152_bb0125","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1080\/14686996.2019.1627174","article-title":"PEGylated liposomes: immunological responses","volume":"20","author":"Mohamed","year":"2019","journal-title":"Sci. Technol. Adv. Mater."},{"issue":"7","key":"10.1016\/j.ijbiomac.2022.11.152_bb0130","doi-asserted-by":"crossref","DOI":"10.3390\/molecules23071700","article-title":"Understanding the role of anti-PEG antibodies in the complement activation by doxil in vitro","volume":"23","author":"Neun","year":"2018","journal-title":"Molecules"},{"issue":"5","key":"10.1016\/j.ijbiomac.2022.11.152_bb0135","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1002\/wnan.1339","article-title":"Anti-PEG immunity: emergence, characteristics, and unaddressed questions","volume":"7","author":"Yang","year":"2015","journal-title":"Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol."},{"issue":"3","key":"10.1016\/j.ijbiomac.2022.11.152_bb0140","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.addr.2010.09.001","article-title":"A multifunctional envelope type nano device (MEND) for gene delivery to tumours based on the EPR effect: a strategy for overcoming the PEG dilemma","volume":"63","author":"Hatakeyama","year":"2011","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"2","key":"10.1016\/j.ijbiomac.2022.11.152_bb0145","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1210\/en.2009-1082","article-title":"Nanoparticles and the immune system","volume":"151","author":"Zolnik","year":"2010","journal-title":"Endocrinology"},{"issue":"1","key":"10.1016\/j.ijbiomac.2022.11.152_bb0150","first-page":"100","article-title":"Cell membrane coating technology: a promising strategy for biomedical applications","volume":"11","author":"Liu","year":"2019","journal-title":"Nanomicro Lett"},{"key":"10.1016\/j.ijbiomac.2022.11.152_bb0155","article-title":"Cell membrane-encapsulated nanoparticles for vaccines and immunotherapy","author":"Xiang","year":"2021","journal-title":"Particuology"},{"issue":"6","key":"10.1016\/j.ijbiomac.2022.11.152_bb0160","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202002081","article-title":"Recent advances in cell membrane-derived biomimetic nanotechnology for cancer immunotherapy","volume":"10","author":"Raza","year":"2021","journal-title":"Adv. Healthc. Mater."},{"key":"10.1016\/j.ijbiomac.2022.11.152_bb0165","first-page":"879","article-title":"Cell-mediated and cell membrane-coated nanoparticles for drug delivery and cancer therapy","volume":"3","author":"Yaman","year":"2020","journal-title":"Cancer Drug Resist."},{"key":"10.1016\/j.ijbiomac.2022.11.152_bb0170","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.jconrel.2020.09.012","article-title":"Cell membrane coated nanocarriers - an efficient biomimetic platform for targeted therapy","volume":"327","author":"Dash","year":"2020","journal-title":"J. Control. Release"},{"issue":"6122","key":"10.1016\/j.ijbiomac.2022.11.152_bb0175","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1126\/science.1229568","article-title":"Minimal, \"Self\" peptides that inhibit phagocytic clearance and enhance delivery of nanoparticles","volume":"339","author":"Rodriguez","year":"2013","journal-title":"Science"},{"issue":"6","key":"10.1016\/j.ijbiomac.2022.11.152_bb0180","doi-asserted-by":"crossref","DOI":"10.1093\/nsr\/nwab039","article-title":"Red blood cell membrane-camouflaged nanoparticles loaded with AIEgen and poly (I: C) for enhanced tumoral photodynamic-immunotherapy","volume":"8","author":"Dai","year":"2021","journal-title":"Natl. Sci. Rev."},{"key":"10.1016\/j.ijbiomac.2022.11.152_bb0185","doi-asserted-by":"crossref","DOI":"10.1021\/acsnano.0c07721","article-title":"Fighting immune cold and reprogramming immunosuppressive tumor microenvironment with red blood cell membrane-camouflaged nanobullets","author":"Yang","year":"2020","journal-title":"ACS Nano"},{"issue":"22","key":"10.1016\/j.ijbiomac.2022.11.152_bb0190","doi-asserted-by":"crossref","first-page":"25635","DOI":"10.1021\/acsami.1c02581","article-title":"Platelet membrane-coated and VAR2CSA malaria protein-functionalized nanoparticles for targeted treatment of primary and metastatic cancer","volume":"13","author":"Zhou","year":"2021","journal-title":"ACS Appl. Mater. Interfaces"},{"issue":"22","key":"10.1016\/j.ijbiomac.2022.11.152_bb0195","article-title":"Platelet membrane-camouflaged magnetic nanoparticles for ferroptosis-enhanced cancer immunotherapy","volume":"16","author":"Jiang","year":"2020","journal-title":"Small"},{"issue":"1","key":"10.1016\/j.ijbiomac.2022.11.152_bb0200","doi-asserted-by":"crossref","first-page":"164","DOI":"10.7150\/thno.47841","article-title":"Macrophage membrane functionalized biomimetic nanoparticles for targeted anti-atherosclerosis applications","volume":"11","author":"Wang","year":"2021","journal-title":"Theranostics"},{"issue":"13","key":"10.1016\/j.ijbiomac.2022.11.152_bb0205","doi-asserted-by":"crossref","first-page":"5522","DOI":"10.1021\/acs.nanolett.1c00818","article-title":"Tumor-associated-macrophage-membrane-coated nanoparticles for improved photodynamic immunotherapy","volume":"21","author":"Chen","year":"2021","journal-title":"Nano Lett."},{"issue":"39","key":"10.1016\/j.ijbiomac.2022.11.152_bb0210","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202003368","article-title":"T-cell-mimicking nanoparticles for cancer immunotherapy","volume":"32","author":"Kang","year":"2020","journal-title":"Adv. Mater."},{"key":"10.1016\/j.ijbiomac.2022.11.152_bb0215","doi-asserted-by":"crossref","DOI":"10.1016\/j.msec.2020.111670","article-title":"Tumor cell membrane-derived nano-trojan horses encapsulating phototherapy and chemotherapy are accepted by homologous tumor cells","volume":"120","author":"Zhang","year":"2021","journal-title":"Mater. Sci. Eng. C Mater. Biol. Appl."},{"key":"10.1016\/j.ijbiomac.2022.11.152_bb0220","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.jconrel.2021.04.013","article-title":"Smart biomimetic metal organic frameworks based on ROS-ferroptosis-glycolysis regulation for enhanced tumor chemo-immunotherapy","volume":"334","author":"Yang","year":"2021","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijbiomac.2022.11.152_bb0225","doi-asserted-by":"crossref","first-page":"2873","DOI":"10.2147\/IJN.S242787","article-title":"Doxorubicin delivered using nanoparticles camouflaged with mesenchymal stem cell membranes to treat colon cancer","volume":"15","author":"Liu","year":"2020","journal-title":"Int. J. Nanomedicine"},{"issue":"19","key":"10.1016\/j.ijbiomac.2022.11.152_bb0230","doi-asserted-by":"crossref","first-page":"8998","DOI":"10.1039\/D0NR08024A","article-title":"Doxorubicin and PD-L1 siRNA co-delivery with stem cell membrane-coated polydopamine nanoparticles for the targeted chemoimmunotherapy of PCa bone metastases","volume":"13","author":"Mu","year":"2021","journal-title":"Nanoscale"},{"issue":"37","key":"10.1016\/j.ijbiomac.2022.11.152_bb0235","doi-asserted-by":"crossref","first-page":"41138","DOI":"10.1021\/acsami.0c13169","article-title":"Bacterial vesicle-cancer cell hybrid membrane-coated nanoparticles for tumor specific immune activation and photothermal therapy","volume":"12","author":"Wang","year":"2020","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.ijbiomac.2022.11.152_bb0240","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.actbio.2020.05.028","article-title":"Hybrid cell membrane-coated nanoparticles: a multifunctional biomimetic platform for cancer diagnosis and therapy","volume":"112","author":"Chen","year":"2020","journal-title":"Acta Biomater."},{"key":"10.1016\/j.ijbiomac.2022.11.152_bb0245","doi-asserted-by":"crossref","DOI":"10.1016\/j.nantod.2020.100972","article-title":"Inorganic nanoparticles in clinical trials and translations","volume":"35","author":"Huang","year":"2020","journal-title":"Nano Today"},{"issue":"3","key":"10.1016\/j.ijbiomac.2022.11.152_bb0250","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1038\/s41565-018-0356-z","article-title":"Nanoparticles promote in vivo breast cancer cell intravasation and extravasation by inducing endothelial leakiness","volume":"14","author":"Peng","year":"2019","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.ijbiomac.2022.11.152_bb0255","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1021\/ma60078a020","article-title":"Triple-helical structure of (1\u2192 3)-\u03b2-D-glucan","volume":"13","author":"Deslandes","year":"1980","journal-title":"Macromolecules"},{"issue":"9","key":"10.1016\/j.ijbiomac.2022.11.152_bb0260","doi-asserted-by":"crossref","first-page":"10727","DOI":"10.1021\/acsnano.9b05436","article-title":"Dynamic and hierarchically structured networks with tissue-like mechanical behavior","volume":"13","author":"Wu","year":"2019","journal-title":"ACS Nano"},{"issue":"3","key":"10.1016\/j.ijbiomac.2022.11.152_bb0265","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/j.cell.2020.09.058","article-title":"Innate immune training of granulopoiesis promotes anti-tumor activity","volume":"183","author":"Kalafati","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.ijbiomac.2022.11.152_bb0270","doi-asserted-by":"crossref","DOI":"10.1016\/j.carbpol.2021.117988","article-title":"Oxidized curdlan activates dendritic cells and enhances antitumor immunity","volume":"264","author":"Bao","year":"2021","journal-title":"Carbohydr. Polym."},{"key":"10.1016\/j.ijbiomac.2022.11.152_bb0275","doi-asserted-by":"crossref","first-page":"658","DOI":"10.3389\/fimmu.2020.00658","article-title":"Structure-functional activity relationship of beta-glucans from the perspective of immunomodulation: a mini-review","volume":"11","author":"Han","year":"2020","journal-title":"Front. Immunol."},{"issue":"2","key":"10.1016\/j.ijbiomac.2022.11.152_bb0280","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1007\/s00262-020-02707-4","article-title":"Curdlan, zymosan and a yeast-derived beta-glucan reshape tumor-associated macrophages into producers of inflammatory chemo-attractants","volume":"70","author":"de Graaff","year":"2021","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.ijbiomac.2022.11.152_bb0285","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/0144-8617(94)90018-3","article-title":"Effect of heating on formation of curdlan gels","volume":"24","author":"Tokuya Harada","year":"1994","journal-title":"Carbohydr. Polym."},{"issue":"1","key":"10.1016\/j.ijbiomac.2022.11.152_bb0290","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/0263-7855(96)00018-5","article-title":"VMD: visual molecular dynamics","volume":"14","author":"William Humphrey","year":"1996","journal-title":"J. Mol. Graph."},{"issue":"27","key":"10.1016\/j.ijbiomac.2022.11.152_bb0295","doi-asserted-by":"crossref","first-page":"10980","DOI":"10.1073\/pnas.1106634108","article-title":"Erythrocyte membrane-camouflaged polymeric nanoparticles as a biomimetic delivery platform","volume":"108","author":"Hu","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ijbiomac.2022.11.152_bb0300","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2017.00299","article-title":"Anhuienoside C ameliorates collagen-induced arthritis through inhibition of MAPK and NF-\u03baB signaling pathways","volume":"8","author":"Liu","year":"2017","journal-title":"Front. Pharmacol."},{"issue":"16","key":"10.1016\/j.ijbiomac.2022.11.152_bb0305","doi-asserted-by":"crossref","first-page":"4586","DOI":"10.1158\/0008-5472.CAN-17-3841","article-title":"Hypoxic tumor-derived exosomal miR-301a mediates M2 macrophage polarization via PTEN\/PI3K gamma to promote pancreatic cancer metastasis","volume":"78","author":"Wang","year":"2018","journal-title":"Cancer Res."},{"issue":"3","key":"10.1016\/j.ijbiomac.2022.11.152_bb0310","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1007\/BF00300234","article-title":"Determination of subcutaneous tumor size in athymic (nude) mice","volume":"24","author":"Tomayko","year":"1989","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.ijbiomac.2022.11.152_bb0315","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2020.153356","article-title":"Novel chinese Angelica polysaccharide biomimetic nanomedicine to curcumin delivery for hepatocellular carcinoma treatment and immunomodulatory effect","volume":"80","author":"Guo","year":"2021","journal-title":"Phytomedicine"},{"issue":"21","key":"10.1016\/j.ijbiomac.2022.11.152_bb0320","doi-asserted-by":"crossref","first-page":"24532","DOI":"10.1021\/acsami.1c05644","article-title":"Erythrocyte membrane-camouflaged PCN-224 nanocarriers integrated with platinum nanoparticles and glucose oxidase for enhanced tumor sonodynamic therapy and synergistic starvation therapy","volume":"13","author":"Bao","year":"2021","journal-title":"ACS Appl. Mater. Interfaces"},{"issue":"44","key":"10.1016\/j.ijbiomac.2022.11.152_bb0325","doi-asserted-by":"crossref","first-page":"7043","DOI":"10.1002\/adma.201503323","article-title":"Anticancer platelet-mimicking nanovehicles","volume":"27","author":"Hu","year":"2015","journal-title":"Adv. Mater."},{"issue":"26","key":"10.1016\/j.ijbiomac.2022.11.152_bb0330","doi-asserted-by":"crossref","first-page":"10461","DOI":"10.1002\/anie.202002782","article-title":"A biomimetic nanoparticle to \"lure and kill\" phospholipase A2","volume":"59","author":"Zhang","year":"2020","journal-title":"Angew. Chem. Int. Ed. Engl."},{"issue":"7","key":"10.1016\/j.ijbiomac.2022.11.152_bb0335","doi-asserted-by":"crossref","first-page":"2664","DOI":"10.1039\/c3nr00015j","article-title":"'Marker-of-self' functionalization of nanoscale particles through a top-down cellular membrane coating approach","volume":"5","author":"Hu","year":"2013","journal-title":"Nanoscale"},{"key":"10.1016\/j.ijbiomac.2022.11.152_bb0340","article-title":"A novel liposome-polymer hybrid nanoparticles delivering a multi-epitope self-replication DNA vaccine and its preliminary immune evaluation in experimental animals","volume":"35","author":"Zhao","year":"2021","journal-title":"Nanomedicine"},{"key":"10.1016\/j.ijbiomac.2022.11.152_bb0345","doi-asserted-by":"crossref","first-page":"5083","DOI":"10.2147\/IJN.S258145","article-title":"Chiral active beta-glucan nanoparticles for synergistic delivery of doxorubicin and immune potentiation","volume":"15","author":"Huang","year":"2020","journal-title":"Int. J. Nanomedicine"},{"issue":"1","key":"10.1016\/j.ijbiomac.2022.11.152_bb0350","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0940-9602(11)80424-3","article-title":"pH-induced denaturation of spectrin changes the interaction of membrane proteins in erythrocyte ghosts. Biochemical and electron microscopic evidence","volume":"176","author":"Baumann","year":"1994","journal-title":"Ann. Anat."},{"key":"10.1016\/j.ijbiomac.2022.11.152_bb0355","article-title":"Active stealth and self-positioning biomimetic vesicles achieved effective antitumor therapy","author":"Li","year":"2021","journal-title":"J. Control. Release"},{"issue":"3","key":"10.1016\/j.ijbiomac.2022.11.152_bb0360","doi-asserted-by":"crossref","first-page":"523","DOI":"10.7150\/thno.17259","article-title":"Enhanced blood suspensibility and laser-activated tumor-specific drug release of theranostic mesoporous silica nanoparticles by functionalizing with erythrocyte membranes","volume":"7","author":"Su","year":"2017","journal-title":"Theranostics"}],"container-title":["International Journal of Biological Macromolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813022027118?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813022027118?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T09:59:58Z","timestamp":1758880798000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0141813022027118"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1]]},"references-count":72,"alternative-id":["S0141813022027118"],"URL":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2022.11.152","relation":{},"ISSN":["0141-8130"],"issn-type":[{"value":"0141-8130","type":"print"}],"subject":[],"published":{"date-parts":[[2023,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cell membrane-camouflaged DOX-loaded \u03b2-glucan nanoparticles for highly efficient cancer immunochemotherapy","name":"articletitle","label":"Article Title"},{"value":"International Journal of Biological Macromolecules","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2022.11.152","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}